Lupin’s arm enters into partnership with Endoceutics

09 Mar 2021 Evaluate

Lupin’s subsidiary -- Lupin Pharma has entered into partnership with Endoceutics, a women’s health focused innovative Canadian biotech company, to commercialize Intrarosa in Canada. Intrarosa is Endoceutic’s flagship product indicated for the treatment of postmenopausal vulvovaginal atrophy offered as a vaginal ovule containing 6.5 mg of Prasterone. It is estimated that over 50% of postmenopausal women suffer from the symptoms of vulvovaginal atrophy and that less than 10% of these women are treated with prescription medicines. 

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2179.70 3.45 (0.16%)
19-Jan-2026 14:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1684.00
Dr. Reddys Lab 1175.05
Cipla 1393.30
Zydus Lifesciences 872.95
Lupin 2179.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×